• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

行动证据:一个针对解决抗微生物药物耐药性的干预措施的One Health 学习平台。

Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance.

机构信息

Geneva Transformative Governance Lab, Global Studies Institute, University of Geneva, Geneva, Switzerland; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.

Global Economic Dynamics and the Biosphere, The Royal Swedish Academy of Sciences, Stockholm, Sweden; Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden.

出版信息

Lancet Infect Dis. 2020 Dec;20(12):e307-e311. doi: 10.1016/S1473-3099(20)30392-3. Epub 2020 Aug 24.

DOI:10.1016/S1473-3099(20)30392-3
PMID:32853549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7444982/
Abstract

Improving evidence for action is crucial to tackle antimicrobial resistance. The number of interventions for antimicrobial resistance is increasing but current research has major limitations in terms of efforts, methods, scope, quality, and reporting. Moving the agenda forwards requires an improved understanding of the diversity of interventions, their feasibility and cost-benefit, the implementation factors that shape and underpin their effectiveness, and the ways in which individual interventions might interact synergistically or antagonistically to influence actions against antimicrobial resistance in different contexts. Within the efforts to strengthen the global governance of antimicrobial resistance, we advocate for the creation of an international One Health platform for online learning. The platform will synthesise the evidence for actions on antimicrobial resistance into a fully accessible database; generate new scientific insights into the design, implementation, evaluation, and reporting of the broad range of interventions relevant to addressing antimicrobial resistance; and ultimately contribute to the goal of building societal resilience to this central challenge of the 21st century.

摘要

为了应对抗微生物药物耐药性,提高行动证据至关重要。针对抗微生物药物耐药性的干预措施数量正在增加,但目前的研究在努力程度、方法、范围、质量和报告方面存在重大局限性。要推动这项议程向前发展,就需要更好地了解干预措施的多样性、它们的可行性和成本效益、影响其有效性的实施因素,以及个体干预措施在不同情况下如何相互协同或拮抗地影响对抗抗微生物药物耐药性的行动。在加强抗微生物药物耐药性全球治理的努力中,我们倡导创建一个在线学习的全球卫生国际平台。该平台将把针对抗微生物药物耐药性的行动证据综合到一个完全可访问的数据库中;针对广泛干预措施的设计、实施、评估和报告,生成新的科学见解,以应对抗微生物药物耐药性;并最终有助于实现建立社会对 21 世纪这一核心挑战的韧性的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecbb/7444982/2b2d4aa11ba0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecbb/7444982/2b2d4aa11ba0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecbb/7444982/2b2d4aa11ba0/gr1_lrg.jpg

相似文献

1
Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance.行动证据:一个针对解决抗微生物药物耐药性的干预措施的One Health 学习平台。
Lancet Infect Dis. 2020 Dec;20(12):e307-e311. doi: 10.1016/S1473-3099(20)30392-3. Epub 2020 Aug 24.
2
AMR-Intervene: a social-ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective.AMR-Intervene:一个从“同一健康”视角出发的捕捉解决抗菌素耐药性行动多样性的社会-生态框架。
J Antimicrob Chemother. 2021 Jan 1;76(1):1-21. doi: 10.1093/jac/dkaa394.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Scope and applicability of social-ecological resilience to antimicrobial resistance.社会生态弹性对抗微生物药物耐药性的范围和适用性。
Lancet Planet Health. 2023 Jul;7(7):e630-e637. doi: 10.1016/S2542-5196(23)00128-6.
5
Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.衡量 2020-21 年全球对抗微生物药物耐药性的反应:对 114 个国家的系统治理分析。
Lancet Infect Dis. 2023 Jun;23(6):706-718. doi: 10.1016/S1473-3099(22)00796-4. Epub 2023 Jan 16.
6
Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.探索促成抗微生物药物耐药性干预措施成功实施的因素:高收入和中低收入国家的比较。
Front Public Health. 2023 Oct 13;11:1230848. doi: 10.3389/fpubh.2023.1230848. eCollection 2023.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.采取“联合国整体办法”防治抗微生物药物耐药性? 对国际组织的任务和活动进行的制图。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008181.
9
An approach for embedding behavioural science in antimicrobial resistance One Health research.将行为科学嵌入抗菌药物耐药性的“同一健康”研究的方法。
J Infect Public Health. 2023 Dec;16 Suppl 1:134-140. doi: 10.1016/j.jiph.2023.11.001. Epub 2023 Nov 4.
10
The governance of antimicrobial resistance in Brazil: Challenges for developing and implementing a one health agenda.巴西的抗菌药物耐药性治理:制定和实施“同一健康”议程的挑战。
Glob Public Health. 2023 Jan;18(1):2190381. doi: 10.1080/17441692.2023.2190381.

引用本文的文献

1
'When global health meets global goals': assessing the alignment between antimicrobial resistance and sustainable development policies in 10 African and Asian countries.“当全球健康遇上全球目标”:评估10个亚非国家抗菌药物耐药性与可持续发展政策之间的一致性
BMJ Glob Health. 2025 Mar 11;10(3):e017837. doi: 10.1136/bmjgh-2024-017837.
2
Social and ecological determinants of antimicrobial resistance in Africa: a systematic review of epidemiological evidence.非洲抗菌素耐药性的社会和生态决定因素:流行病学证据的系统评价
Antimicrob Steward Healthc Epidemiol. 2024 Sep 9;4(1):e119. doi: 10.1017/ash.2024.375. eCollection 2024.
3

本文引用的文献

1
Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review.研究报告质量是干预措施减少抗生素使用的一个障碍,阻碍了基于循证的抗菌素耐药性政策制定:系统综述。
J Antimicrob Chemother. 2020 May 1;75(5):1091-1098. doi: 10.1093/jac/dkz540.
2
Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.在英国急症医院信托基金中实施用于预防、管理和控制产碳青霉烯酶肠杆菌科的工具包:定性评估。
BMC Health Serv Res. 2019 Oct 12;19(1):689. doi: 10.1186/s12913-019-4492-4.
3
The impacts of animal agriculture on One Health-Bacterial zoonosis, antimicrobial resistance, and beyond.
畜牧业对“同一健康”的影响——细菌性人畜共患病、抗菌药物耐药性及其他方面。
One Health. 2024 May 8;18:100748. doi: 10.1016/j.onehlt.2024.100748. eCollection 2024 Jun.
4
Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.探索促成抗微生物药物耐药性干预措施成功实施的因素:高收入和中低收入国家的比较。
Front Public Health. 2023 Oct 13;11:1230848. doi: 10.3389/fpubh.2023.1230848. eCollection 2023.
5
The Past, Present, and Future of One Health in India: A Narrative Review.印度“同一健康”的过去、现在与未来:叙事性综述
Cureus. 2023 Sep 10;15(9):e44992. doi: 10.7759/cureus.44992. eCollection 2023 Sep.
6
Cross-sectional health centre and community-based evaluation of the impact of pneumococcal and malaria vaccination on antibiotic prescription and usage, febrile illness and antimicrobial resistance in young children in Malawi: the IVAR study protocol. Malawi 中基于社区的肺炎球菌和疟疾疫苗接种对儿童抗生素处方和使用、发热性疾病和抗菌素耐药性影响的横断面卫生中心和社区评估:IVAR 研究方案。
BMJ Open. 2023 May 12;13(5):e069560. doi: 10.1136/bmjopen-2022-069560.
7
Factors impacting antimicrobial resistance in the South East Asian food system and potential places to intervene: A participatory, one health study.影响东南亚食品系统中抗菌药物耐药性的因素及潜在干预点:一项参与性“同一健康”研究。
Front Microbiol. 2023 Jan 5;13:992507. doi: 10.3389/fmicb.2022.992507. eCollection 2022.
8
Introducing the global antimicrobial stewardship partnership hub (GASPH): creating conditions for successful global partnership collaboration.介绍全球抗菌药物管理伙伴关系中心(GASPH):为成功开展全球伙伴关系合作创造条件。
JAC Antimicrob Resist. 2022 Nov 8;4(6):dlac115. doi: 10.1093/jacamr/dlac115. eCollection 2022 Dec.
9
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review.制定人类健康领域抗菌药物耐药性全球优先研究议程:范围综述方案。
BMJ Open. 2022 Jun 2;12(6):e060553. doi: 10.1136/bmjopen-2021-060553.
10
Studying Factors Affecting Success of Antimicrobial Resistance Interventions through the Lens of Experience: A Thematic Analysis.通过经验视角研究影响抗菌药物耐药性干预措施成功的因素:一项主题分析。
Antibiotics (Basel). 2022 May 10;11(5):639. doi: 10.3390/antibiotics11050639.
A governance framework for development and assessment of national action plans on antimicrobial resistance.
国家抗菌素耐药性行动计划制定和评估的治理框架。
Lancet Infect Dis. 2019 Nov;19(11):e371-e384. doi: 10.1016/S1473-3099(19)30415-3. Epub 2019 Oct 3.
4
Defining and combating antibiotic resistance from One Health and Global Health perspectives.从“同一健康”和“全球健康”的角度定义和对抗抗生素耐药性。
Nat Microbiol. 2019 Sep;4(9):1432-1442. doi: 10.1038/s41564-019-0503-9. Epub 2019 Aug 22.
5
Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine.抗生素审查工具包 (ARK) 的干预计划:一项数字和行为干预措施,旨在安全审查和减少急性和普通医学中的抗生素处方。
J Antimicrob Chemother. 2019 Nov 1;74(11):3362-3370. doi: 10.1093/jac/dkz333.
6
Impact of vaccination on antibiotic usage: a systematic review and meta-analysis.疫苗接种对抗生素使用的影响:系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Oct;25(10):1213-1225. doi: 10.1016/j.cmi.2019.06.030. Epub 2019 Jul 5.
7
Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.政府干预减少人类抗生素使用的政策:系统评价和证据图谱。
PLoS Med. 2019 Jun 11;16(6):e1002819. doi: 10.1371/journal.pmed.1002819. eCollection 2019 Jun.
8
Complex health interventions in complex systems: improving the process and methods for evidence-informed health decisions.复杂系统中的复杂健康干预措施:改进基于证据的健康决策的流程和方法。
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000963. doi: 10.1136/bmjgh-2018-000963. eCollection 2019.
9
Taking account of context in systematic reviews and guidelines considering a complexity perspective.从复杂性视角出发,在系统评价和指南中考虑背景因素。
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000840. doi: 10.1136/bmjgh-2018-000840. eCollection 2019.
10
The quality of studies evaluating antimicrobial stewardship interventions: a systematic review.评价抗菌药物管理干预措施的研究质量:系统评价。
Clin Microbiol Infect. 2019 May;25(5):555-561. doi: 10.1016/j.cmi.2018.11.002. Epub 2018 Nov 23.